» Articles » PMID: 33407612

Effects of Time-restricted Feeding in Weight Loss, Metabolic Syndrome and Cardiovascular Risk in Obese Women

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2021 Jan 7
PMID 33407612
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increasing prevalence of overweight and obesity among the worldwide population has been associated with a range of adverse health consequences such as Type 2 diabetes and cardiovascular diseases. The metabolic syndrome (MetS) is a cluster of cardiometabolic abnormalities that occur more commonly in overweight individuals. Time-restricted feeding (TRF) is a dietary approach used for weight loss and overall health. TRF may be an option for those subjects who struggle with extreme restriction diets with foods that generally do not belong to an individual's habits.

Objective: The purpose of this study was to determine the effect of TRF on body composition and the association of weight loss with metabolic and cardiovascular risks in obese middle-aged women.

Methods: A non-randomized controlled clinical trial was performed over 3 months in obese women (TRF group, n = 20, BMI 32.53 ± 1.13 vs. Control n = 12, BMI 34.55 ± 1.20). The TRF protocol adopted was 16 h without any energy intake followed by 8 h of normal food intake.

Main Outcomes And Measures: Anthropometric measurements, body composition, blood biomarkers, cardiovascular risk in 30 years (CVDRisk30y), and quality of life were evaluated at baseline and after the 3 months.

Results: TRF was effective in reducing weight (~ 4 kg), BMI, % of body fat (%BF), waist circumference from baseline without changes in blood biomarkers associated with MetS. TRF promoted a reduction in CVDRisk30y (12%) wich was moderately correlated with %BF (r = 0.62, n = 64, p < 0.001) and %MM (r = - 0.74, n = 64, p < 0.001).

Conclusions: TRF protocol reduces body weight without changes in biomarkers related to MetS. In addition, the anthropometric evaluation that predicts %BF and %MM could be used as an approach to follow individuals engaged in the TRF regimen since they correlate with cardiovascular risk.

Citing Articles

Time Restricted Eating: A Valuable Alternative to Calorie Restriction for Addressing Obesity?.

Parrotta M, Colangeli L, Scipione V, Vitale C, Sbraccia P, Guglielmi V Curr Obes Rep. 2025; 14(1):17.

PMID: 39899119 PMC: 11790783. DOI: 10.1007/s13679-025-00609-z.


Evaluating the effects of time-restricted eating on overweight and obese women with polycystic ovary syndrome: A randomized controlled trial study protocol.

Liu H, Shangguan F, Liu F, Guo Y, Yu H, Li H PLoS One. 2025; 20(1):e0316333.

PMID: 39787136 PMC: 11717230. DOI: 10.1371/journal.pone.0316333.


Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis.

Khalafi M, Rosenkranz S, Ghasemi F, Kheradmand S, Habibi Maleki A, Korivi M Nutr Metab (Lond). 2025; 22(1):1.

PMID: 39762987 PMC: 11706068. DOI: 10.1186/s12986-024-00885-x.


Weight-neutral early time-restricted eating improves glycemic variation and time in range without changes in inflammatory markers.

Bruno J, Walker J, Nasserifar S, Upadhyay D, Ronning A, Vanegas S iScience. 2025; 27(12):111501.

PMID: 39759025 PMC: 11699278. DOI: 10.1016/j.isci.2024.111501.


New insight on the potential detrimental effect of metabolic syndrome on the Alzheimer disease neuropathology: Mechanistic role.

Ali N, Al-Kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Bahaa M J Cell Mol Med. 2024; 28(23):e70118.

PMID: 39644152 PMC: 11624485. DOI: 10.1111/jcmm.70118.


References
1.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

2.
Wilkinson M, Manoogian E, Zadourian A, Lo H, Fakhouri S, Shoghi A . Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab. 2019; 31(1):92-104.e5. PMC: 6953486. DOI: 10.1016/j.cmet.2019.11.004. View

3.
Weinberger N, Kersting A, Riedel-Heller S, Luck-Sikorski C . Body Dissatisfaction in Individuals with Obesity Compared to Normal-Weight Individuals: A Systematic Review and Meta-Analysis. Obes Facts. 2016; 9(6):424-441. PMC: 5644896. DOI: 10.1159/000454837. View

4.
Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

5.
Stefan N, Haring H, Hu F, Schulze M . Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2014; 1(2):152-62. DOI: 10.1016/S2213-8587(13)70062-7. View